Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 39073

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesPAMAM dendrimer G3.0 amine (PAMAM G3.0) is a polyamidoamine (PAMAM) dendrimer with amine termini that has been used as a drug delivery system in vivo.1,2 It is approximately 36 Å in diameter and has 32 surface groups.1 It is cytotoxic to DU145 cells (IC50 = ~13.42 µM) and toxic to zebrafish embryos, inducing mortality 72 hours post-fertilization when used at a concentration of 0.2 µM.3 Liposomes coated with PAMAM G3.0 and encapsulating the isoquinoline alkaloid berberine (Item No. 10006427) and the anthraquinone chrysophanol (Item No. 19870) reduce hydrogen peroxide-induced production of reactive oxygen species (ROS) in ARPE-19 retinal epithelial cells and protect against retinal damage in a rat model of photooxidation-induced age-related macular degeneration (AMD).2
WARNING This product is not for human or veterinary use.
1. Developmental toxicity of low generation PAMAM dendrimers in zebrafish. Toxicol. Appl. Pharmacol. 225(1), 70-79 (2007).
2. Liposomes for effective drug delivery to the ocular posterior chamber. J. Nanobiotechnology 17(1), 64 (2019).
3. Differences in toxicity of anionic and cationic PAMAM and PPI dendrimers in zebrafish embryos and cancer cell lines. Toxicol. Appl. Pharmacol. 305, 83-92 (2016).